North America Gene Editing Breakthroughs Boosting CRISPR and Cas Genes Market Growth by 2034
The North American biotechnology and life sciences sector continues to play a significant role in advancing gene-editing technologies. Increasing investments in genomic research, precision medicine, and advanced therapeutic development are supporting the adoption of CRISPR and CRISPR-associated (Cas) gene technologies across the region. Research institutions, biotechnology companies, and...
0 Commentaires 0 Parts 509 Vue 0 Aperçu